racemetirosine has been researched along with Disseminated Intravascular Coagulation in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagata, M | 1 |
| Takayama, T | 1 |
| Nishijima, N | 1 |
| Mugiya, S | 1 |
| Ushiyama, T | 1 |
| Ozono, S | 1 |
1 other study available for racemetirosine and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
[Clinical course of patient with malignant pheochromocytoma who was treated with CVD chemotherapy and alpha-methyl-p-tyrosine].
Topics: Adult; alpha-Methyltyrosine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacar | 2010 |